NEW YORK (GenomeWeb) – Invitae said today that it has acquired health software developer Ommdom and its genomic management tool CancerGene Connect, an end-to-end platform for collecting and managing genetic family histories.

Under the terms of the agreement, Invitae acquired all Ommdom's outstanding capital stock in exchange for approximately $6 million in Invitae common stock.

According to Invitae, the acquisition expands its existing suite of technologies that help patients and clinicians use genetic information as part of mainstream medical care.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.